Novellia Wins the MedTech Breakthrough Award for Best Healthcare Data Repository Solution for the Second Year in a Row

For the second consecutive year, Novellia has been named Best Healthcare Data Repository Solution by the MedTech Breakthrough Awards program, one of the most recognized independent recognitions in global healthcare technology. The win arrives as the program celebrates its 10th annual awards, marking a decade of identifying companies that are genuinely shaping the direction of healthcare innovation.

Back-to-back recognition from any independent program is notable. From one with a 10-year track record and no commercial relationship with its nominees, it carries a different weight. This post covers what the MedTech Breakthrough Award is, how the selection process works, and what winning it twice means for Novellia and the organizations it serves.

‍

What Is the MedTech Breakthrough Award?

The MedTech Breakthrough Award is an annual recognition program administered by MedTech Breakthrough, an independent market intelligence organization focused on healthcare technology innovation. The program evaluates hundreds of nominations from companies across the United States, Europe, and beyond, recognizing excellence across categories including digital health, medical devices, clinical trials technology, and healthcare data. MedTech Breakthrough has no commercial relationship with nominees, which is what gives its selections independent credibility.

Winners are selected based on three primary criteria: the degree of innovation demonstrated, clinical and commercial impact, and how meaningfully a solution advances its category. The program does not recognize potential or roadmaps. It recognizes what is built, deployed, and producing results.

The 10th annual program carries particular significance. A decade of selections creates a body of evidence. Organizations and researchers in the healthcare technology space now treat the award's track record as a meaningful signal, not just a list. When a company appears on it once, it says something. When it appears twice in a row, it says something different.

The Best Healthcare Data Repository Solution category specifically recognizes platforms that advance how health data is collected, organized, and made usable for research and patient care. It is one of the more competitive categories in the program, evaluated at the intersection of technical infrastructure, data integrity, and real-world clinical utility.

‍

Novellia's Second Consecutive Win

Novellia was selected from a global field of nominees for the second consecutive year in a program that evaluated hundreds of submissions across the healthcare technology sector.

The platform that earned the recognition is built around a single foundational premise: patients choose what to share. Novellia helps patients find and unify up to 20 years of medical data from disparate hospital systems, physicians' offices, and laboratories across the United States, all in seconds. Patients receive a free, comprehensive view of their health history. Biopharma and pharmaceutical research teams receive anonymized, harmonized datasets drawn from that patient-authorized contribution, giving them real-world evidence built on consent rather than extraction.

That approach is what the judges evaluated in back-to-back cycles, and what they returned to the same conclusion on.

"Winning this award once says we built something that works," said Shashi Shankar, CEO of Novellia. "Winning it twice, especially in the program's 10th year, says we are building something that lasts. Two consecutive years of external validation tells us the market is reaching the same conclusion our customers already reached."

The platform's reach reflects that conclusion. Novellia counts multiple top-10 global biopharma companies among its customers on multi-year contracts, a commercial track record that informed the same criteria the MedTech Breakthrough program uses to evaluate submissions.

‍

Why Two Consecutive Wins Mean More Than One

Most awards recognize a moment. A second consecutive win from the same independent body recognizes a direction.

The MedTech Breakthrough program's criteria include commercial impact, which means customer adoption is part of the evaluation, not just technical architecture or market positioning. Returning to the same company in consecutive cycles reflects a judgment that the solution is not only working but advancing. It is the difference between recognizing a promising approach and confirming a proven one.

That judgment sits alongside other independent validations Novellia has accumulated. The company is backed by peer-reviewed research presented at ASCO and SABCS-AACR, two of the most rigorous forums in oncology and cancer research. It has also been named one of 10 start-up companies to watch by Digital Health New York. Taken together, these recognitions trace a consistent line: across academic, clinical, and commercial evaluation, the model holds up.

The 10th anniversary context amplifies that signal further. A program with a decade of picks has a reference class. Industry participants can look at the full body of MedTech Breakthrough selections and evaluate where a company sits within it. Appearing in the 10th annual program, in a competitive category, for the second consecutive year, is a position that a track record makes meaningful.

‍

What This Means for Novellia's Customers and Partners

For the biopharma and pharmaceutical research teams working with Novellia, the recognition confirms what they already know about the platform. An independent program with global scope and no commercial stake in the outcome evaluated the same approach those teams chose to build on, and reached the same conclusion twice.

For organizations that have not yet worked with Novellia, the award offers a third-party reference point. Evaluating a new data partner involves assessing technical capability, data quality, and track record. A back-to-back MedTech Breakthrough win, in a program that weights commercial impact alongside innovation, is a meaningful input to that evaluation.

The consecutive recognition also signals organizational maturity. Winning an award once can reflect a strong moment in product development. Winning it in the following year, as the product continues to scale and the customer roster grows, reflects a company that is improving as it expands, not just sustaining.

‍

‍

Frequently Asked Questions

What is the MedTech Breakthrough Award?

The MedTech Breakthrough Award is an annual recognition program administered by MedTech Breakthrough, an independent market intelligence organization. It evaluates hundreds of nominations globally and recognizes innovation in healthcare technology across categories including digital health, medical devices, and healthcare data. The program has no commercial relationship with nominees.

Who won the MedTech Breakthrough Award for Best Healthcare Data Repository Solution in 2026?

Novellia was named Best Healthcare Data Repository Solution at the 10th Annual MedTech Breakthrough Awards in 2026. It was the second consecutive year Novellia received this recognition.

How does MedTech Breakthrough select award winners?

MedTech Breakthrough evaluates nominations on innovation, clinical and commercial impact, and the degree to which a solution advances its category. The organization has no commercial relationship with nominees, making its selections fully independent.

What other recognitions has Novellia received?

Novellia has been named one of 10 start-up companies to watch by Digital Health New York and is backed by peer-reviewed research presented at ASCO and SABCS-AACR medical congresses.

‍